• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

频繁出现致病变异的原因包括生育年龄的低外显率、反复的新生突变和遗传漂变。

Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift.

作者信息

Møller Pål, Dominguez-Valentin Mev, Rødland Einar Andreas, Hovig Eivind

机构信息

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Part of Oslo University Hospital, Oslo 0424, Norway.

Center for Hereditary Tumors, HELIOS-Klinikum Wuppertal, University of Witten-Herdecke, Wuppertal 42283, Germany.

出版信息

Cancers (Basel). 2019 Jan 23;11(2):132. doi: 10.3390/cancers11020132.

DOI:10.3390/cancers11020132
PMID:30678073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6406718/
Abstract

We have previously demonstrated that the Norwegian frequent pathogenic ) variants are caused by genetic drift and recurrent de-novo mutations. We here examined the penetrance of frequent variants in fertile ages as a surrogate marker for fitness. We conducted an observational prospective study of penetrance for cancer in Norwegian female carriers of frequent variants, and compared our observed results to penetrance of infrequent variants and to average penetrance of variants reported by others. The cumulative risk for breast cancer at 45 years in carriers of frequent variants was 20% (94% confidence interval 10⁻30%), compared to 35% (95% confidence interval 22⁻48%) in carriers of infrequent variants ( = 0.02), and to the 35% (confidence interval 32⁻39%) average for carriers reported by others ( = 0.0001). Carriers of the most frequent Norwegian variants had low incidence of cancer in fertile ages, indicating a low selective disadvantage. This, together with the variant locations being hotspots for de novo mutations and subject to genetic drift, as previously described, may have caused their high prevalence today. Besides being of theoretical interest to explain the phenomenon that a few variants are frequent, the later onset of breast cancer associated with the most frequent variants may be of interest for carriers who have to decide if and when to select prophylactic mastectomy.

摘要

我们之前已经证明,挪威常见的致病基因变异是由基因漂变和反复出现的新生突变引起的。我们在此研究了育龄期常见基因变异的外显率,将其作为适应性的替代指标。我们对挪威常见基因变异女性携带者的癌症外显率进行了一项观察性前瞻性研究,并将我们观察到的结果与罕见基因变异的外显率以及其他人报告的基因变异平均外显率进行了比较。常见基因变异携带者在45岁时患乳腺癌的累积风险为20%(94%置信区间为10⁻30%),相比之下,罕见基因变异携带者的这一风险为35%(95%置信区间为22⁻48%)(P = 0.02),而其他人报告的基因变异携带者的平均风险为35%(置信区间为32⁻39%)(P = 0.0001)。挪威最常见基因变异的携带者在育龄期患癌率较低,表明选择性劣势较低。如前所述,这一点连同变异位置是新生突变热点且易受基因漂变影响,可能导致了它们如今的高流行率。除了在理论上有助于解释少数基因变异为何常见这一现象外,与最常见基因变异相关的乳腺癌发病较晚这一情况,对于必须决定是否以及何时选择预防性乳房切除术的携带者来说可能具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/6406718/37eb0cac1cb9/cancers-11-00132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/6406718/a226c0f97ebf/cancers-11-00132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/6406718/98f012e84ccb/cancers-11-00132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/6406718/37eb0cac1cb9/cancers-11-00132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/6406718/a226c0f97ebf/cancers-11-00132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/6406718/98f012e84ccb/cancers-11-00132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca15/6406718/37eb0cac1cb9/cancers-11-00132-g003.jpg

相似文献

1
Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift.频繁出现致病变异的原因包括生育年龄的低外显率、反复的新生突变和遗传漂变。
Cancers (Basel). 2019 Jan 23;11(2):132. doi: 10.3390/cancers11020132.
2
Correction: Møller, P.; et al. Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. 2019, , 132.更正:Møller, P. 等人。常见致病变异的原因包括生育年龄的低外显率、反复出现的新发突变和遗传漂变。2019年, ,132。
Cancers (Basel). 2020 Feb 10;12(2):410. doi: 10.3390/cancers12020410.
3
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.常见的遗传变异导致不完全外显:来自无癌症 BRCA1 突变携带者的证据。
Eur J Cancer. 2019 Jan;107:68-78. doi: 10.1016/j.ejca.2018.10.022. Epub 2018 Dec 11.
4
Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.与波兰人群乳腺癌风险增加相关的BRCA1和BRCA2基因结构改变的分子诊断的选定方面
Hered Cancer Clin Pract. 2006 Aug 15;4(3):142-52. doi: 10.1186/1897-4287-4-3-142.
5
6
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.BRCA1基因的1675delA和1135insA突变占挪威家族性乳腺癌-卵巢癌的三分之一,且与较罕见突变相比,这些突变与疾病发病较晚有关。
Dis Markers. 1999 Oct;15(1-3):79-84. doi: 10.1155/1999/278269.
7
Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients.哥伦比亚乳腺癌患者中 BRCA1 和 BRCA2 种系突变的流行率和外显率。
Sci Rep. 2017 Jul 5;7(1):4713. doi: 10.1038/s41598-017-05056-y.
8
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
9
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.在西班牙前往遗传咨询机构的BRCA1和BRCA2基因发生突变的携带者患乳腺癌和卵巢癌的平均累积风险。
Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436.
10
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.巴西非选择性卵巢癌患者中 BRCA1 和 BRCA2 致病性和可能致病性变异体的流行率。
BMC Cancer. 2019 Jan 3;19(1):4. doi: 10.1186/s12885-018-5235-3.

引用本文的文献

1
Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequences.林奇综合征和家族性腺瘤性息肉病中的结直肠癌发生:触发事件及下游后果
Hered Cancer Clin Pract. 2025 Jan 23;23(1):3. doi: 10.1186/s13053-025-00305-y.
2
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic and Variants.病例回顾:全外显子组测序分析鉴定出卵巢癌病例中已知致病性和可能致病性的内含子变异的携带者,这些病例在临床上为阴性。
Genes (Basel). 2022 Apr 15;13(4):697. doi: 10.3390/genes13040697.
3

本文引用的文献

1
Breast Cancer Screening in Denmark.丹麦的乳腺癌筛查
Ann Intern Med. 2017 Oct 3;167(7):524. doi: 10.7326/L17-0270.
2
Cancer risk and survival in carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.携带者的癌症风险和生存情况,按基因和性别分析,直至 75 岁:前瞻性 Lynch 综合征数据库报告。
Gut. 2018 Jul;67(7):1306-1316. doi: 10.1136/gutjnl-2017-314057. Epub 2017 Jul 28.
3
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories.
BRCA1 挪威:对不同实验室在疑似遗传性乳腺癌和卵巢癌家族中检测到的 BRCA1 种系变异进行分类的比较。
Fam Cancer. 2022 Oct;21(4):389-398. doi: 10.1007/s10689-021-00286-6. Epub 2022 Jan 4.
4
Correction: Møller, P.; et al. Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. 2019, , 132.更正:Møller, P. 等人。常见致病变异的原因包括生育年龄的低外显率、反复出现的新发突变和遗传漂变。2019年, ,132。
Cancers (Basel). 2020 Feb 10;12(2):410. doi: 10.3390/cancers12020410.
5
Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing.对经单基因检测未发现遗传病因的家族性癌症病例进行多基因检测panel 的结果。
Sci Rep. 2019 Dec 6;9(1):18555. doi: 10.1038/s41598-019-54517-z.
6
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.林奇综合征中结肠癌分期与筛查间隔的生存率:一项林奇综合征前瞻性数据库报告
Hered Cancer Clin Pract. 2019 Oct 14;17:28. doi: 10.1186/s13053-019-0127-3. eCollection 2019.
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
4
MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis.对有乳腺癌遗传易感性的女性进行MRI筛查:诊断效能及生存分析
Breast Cancer Res Treat. 2014 Dec;148(3):687-8. doi: 10.1007/s10549-014-3178-1. Epub 2014 Nov 15.
5
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.BRCA1 或 BRCA2 基因突变女性行卵巢切除术对癌症发病率和死亡率的影响。
J Clin Oncol. 2014 May 20;32(15):1547-53. doi: 10.1200/JCO.2013.53.2820. Epub 2014 Feb 24.
6
Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway.挪威携带 BRCA1 突变者的乳腺癌特定年龄发病率。
Clin Genet. 2013 Jan;83(1):88-91. doi: 10.1111/j.1399-0004.2012.01855.x. Epub 2012 Mar 1.
7
High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.在一个前瞻性队列中证实了BRCA1和BRCA2突变的高外显率。
Hered Cancer Clin Pract. 2010 Jan 19;8(1):2. doi: 10.1186/1897-4287-8-2.
8
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.BRCA突变的遗传流行病学——家族史仅能检测出不到50%的突变携带者。
Eur J Cancer. 2007 Jul;43(11):1713-7. doi: 10.1016/j.ejca.2007.04.023. Epub 2007 Jun 15.
9
The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations.常见的BRCA1突变1135insA有多种起源:不同人群的单倍型研究。
BMC Med Genet. 2006 Mar 1;7:15. doi: 10.1186/1471-2350-7-15.
10
The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.BRCA1基因中的挪威始祖突变:在一个新发癌症系列研究中证实高外显率,并观察到卵巢癌风险存在差异。
Eur J Cancer. 2003 Oct;39(15):2205-13. doi: 10.1016/s0959-8049(03)00548-3.